EFA vs IBB

iShares MSCI EAFE ETF vs iShares Biotechnology ETF

Quick take
  • EFA has the lower expense ratio at 0.32% vs 0.44% for IBB.
  • EFA pays a higher dividend yield (3.17%).

Side-by-side metrics

MetricEFAIBB
Expense ratio
Annual fee. Lower is better.
0.32%0.44%
Dividend yield
Trailing 12-month yield.
3.17%0.23%
AUM
Assets under management — bigger funds are typically more liquid.
$75.61B$7.95B
YTD return
9.14%3.10%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.890.74
P/E ratio
18.2123.72
Last price
$102.89$170.10
Inception
Issuer
iSharesiShares

EFA top holdings

Top holdings · EFA
ASML.ASASML Holding NV2.48%
HSBA.LHSBC Holdings PLC1.44%
AZN.LAstraZeneca PLC1.36%
ROP.SWRoche Holding AG Ordinary Shares new1.33%
NOVN.SWNovartis AG Registered Shares1.29%
NESN.SWNestle SA1.22%
SHEL.LShell PLC1.18%
SIE.DESiemens AG1.04%
CBA.AXCommonwealth Bank of Australia0.98%
8306.TMitsubishi UFJ Financial Group Inc0.95%
Sector breakdown · EFA
Real Estate1.9%
Consumer Cyclical7.7%
Basic Materials5.9%
Consumer Defensive6.7%
Technology10.3%
Communication Services4.5%
Financial Services24.7%
Utilities4.0%
Industrials19.8%
Energy4.0%
Healthcare10.6%

IBB top holdings

Top holdings · IBB
AMGNAmgen Inc7.37%
GILDGilead Sciences Inc7.32%
VRTXVertex Pharmaceuticals Inc7.21%
REGNRegeneron Pharmaceuticals Inc6.55%
ALNYAlnylam Pharmaceuticals Inc3.71%
ARGXargenx SE ADR3.33%
INSMInsmed Inc2.70%
BIIBBiogen Inc2.67%
NTRANatera Inc2.40%
RVMDRevolution Medicines Inc Ordinary Shares2.27%
Sector breakdown · IBB
Healthcare100.0%

About EFA

EFA (iShares MSCI EAFE ETF) is Developed-market equities outside US/Canada. Managed by iShares, the fund carries $75.6B in assets under management, an expense ratio of 0.32%, a dividend yield of 3.17%. Its largest holding is ASML Holding NV (ASML.AS), which represents 2.5% of the portfolio. Real Estate is the fund's largest sector exposure at 1.9%.

About IBB

IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.